Stockreport

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 [Canadian Business Journal (Canada)]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF PHILADELPHIA and VANCOUVER, British Columbia, Oct. 13, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Co [Read more]